Have you checked out our newsletter?
Stay ahead with expert insights, strategic tips, and industry trends—all designed to boost your brand's med comm initiatives.
"*" indicates required fields
Get fresh insights and candid perspectives on timely issues impacting the pharmaceutical industry from our blog.
The Latest News
Your Speaker’s Bureau Has a Shelf Life: Here’s How to Know When It Needs a Refresh
Nobody wants to be the last one to realize the shelf life of their milk has expired. Yet in biopharma marketing, it happens with speaker’s bureaus more often than most care to admit. The bureau that energetically launched your product three years ago may not be optimized to move your
What’s Trending in BioPharma – March 2026
Europe risks falling behind in the global BioPharma race, the FDA is working to increase accessibility to personalized treatments in rare diseases, and regulators are cracking down on unapproved compounded GLP-1 weight loss drugs. Together, these three stories show the shifting landscape of innovation, regulation, and competition shaping the BioPharma
What’s Trending in BioPharma – February 2026
The BioPharma industry is in rapid flux, shaped by transforming drug pipelines, the ongoing political battle over lowering drug prices, and a new rebate model for the 340B Drug Discount program. Here’s what’s shaping the latest in healthcare. Source: BioPharma International In a recent BioPharm International interview, Janice MacLennan, founder
Launch Broadcast? Yes! Mid Product Life-Cycle? ABSOLUTELY!
One of the most persistent myths about broadcasts is that they are only good for new product launches. The reality is that while product launches are indeed a great time to deploy wide-reaching national broadcasts, their utility extends far beyond this single use. National broadcasts are perfect for announcing newly
What’s Trending in BioPharma – January 2026
The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: BioSpace The biopharma sector is entering 2026 with renewed strength following a market rebound. Analysts point to oncology, neuroscience, and immunology
V2V Wins 2025 International Torch Award
Vision2Voice Healthcare Communications is honored to be named one of five winners of the 2025 BBB International Torch Awards for Ethics! V2V has previously been awarded in the USA at the regional level on five previous occasions, but this recognition marks our first on the international stage. For over a decade,
Introducing KNECT: Upgrade Your KOL ID & Mapping Game with V2V’s Enhanced KOL ID Management Portal
Filtering a spreadsheet to pinpoint the right expert can often feel like finding a needle in a haystack. You asked for a better solution. We listened. V2V is proud to announce our latest software application for visualizing data of Key Opinion Leader (KOL)/Key External Expert (KEE) Identification and Mapping projects.
BioPharma Trends in the News – November 2025
Three recent BioPharma trends are making waves in the industry: breakthroughs in virus imaging for vaccine development, a new FDA pathway to accelerate rare disease treatments, and historic Medicare deals lowering costs for leading obesity and diabetes drugs. Here’s what’s shaping the latest in healthcare. Source: DDW.com Researchers have captured
Roundtable Q&A: The Future of KOL/KEE ID and Mapping
The BioPharma world is a fast-evolving one, but Key Opinion Leaders (KOLs) and Key External Experts (KEEs) remain the core component of transforming awareness into action. What is KOL/KEE Identification and what are some scenarios in which it might be done? KOL/KEE Identification and mapping is pinpointing highly respected, distinguished,